BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$629M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$380M |
| 3 |
Apple
AAPL
|
+$369M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$226M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$161M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.69B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$893M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$361M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$321M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$148M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 9.47% |
| 4 | Financials | 9.13% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Heartland Express
HTLD
$656M
| $231K | ﹤0.01% |
16,626
-7,389
| -31% | -$103K |
|
|
RVNC
2227
DELISTED
Revance Therapeutics, Inc.
RVNC
| $231K | ﹤0.01% |
16,721
+9,445
| +130% | +$131K |
|
2228
QuinStreet
QNST
$930M
| $230K | ﹤0.01% |
22,893
-5,416
| -19% | -$54.5K |
|
2229
Cooper-Standard Automotive
CPS
$667M
| $229K | ﹤0.01% |
45,830
-314
| -0.7% | -$1.57K |
|
2230
Gorman-Rupp
GRC
$1.13B
| $228K | ﹤0.01% |
8,055
+2,734
| +51% | +$77.4K |
|
2231
RadNet
RDNT
$5.69B
| $227K | ﹤0.01% |
13,149
+1,147
| +10% | +$19.8K |
|
|
BRG
2232
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $227K | ﹤0.01% |
8,642
+7,970
| +1,186% | +$210K |
|
|
WW
2233
DELISTED
WW International
WW
| $227K | ﹤0.01% |
35,521
-5,430
| -13% | -$34.7K |
|
|
UMH
2234
UMH Properties
UMH
$1.29B
| $226K | ﹤0.01% |
12,819
+7,234
| +130% | +$128K |
|
2235
Monarch Casino & Resort
MCRI
$1.9B
| $226K | ﹤0.01% |
3,849
-2,017
| -34% | -$118K |
|
|
BFS
2236
Saul Centers
BFS
$785M
| $226K | ﹤0.01% |
4,787
+658
| +16% | +$31K |
|
2237
Prothena Corp
PRTA
$442M
| $225K | ﹤0.01% |
8,299
+5,226
| +170% | +$142K |
|
2238
PAR Technology
PAR
$1.79B
| $225K | ﹤0.01% |
6,004
+3,805
| +173% | +$143K |
|
2239
Crinetics Pharmaceuticals
CRNX
$3.2B
| $225K | ﹤0.01% |
12,042
+8,119
| +207% | +$151K |
|
|
LX
2240
LexinFintech Holdings
LX
$961M
| $223K | ﹤0.01% |
99,988
| – | – |
|
2241
Vanda Pharmaceuticals
VNDA
$266M
| $223K | ﹤0.01% |
20,446
-3,862
| -16% | -$42.1K |
|
2242
Thermon Group Holdings
THR
$844M
| $223K | ﹤0.01% |
15,837
+2,571
| +19% | +$36.1K |
|
2243
Ecopetrol
EC
$18.8B
| $222K | ﹤0.01% |
20,421
+14,574
| +249% | +$158K |
|
2244
Ryerson Holding
RYI
$723M
| $221K | ﹤0.01% |
10,379
+5,092
| +96% | +$108K |
|
2245
Amerant Bancorp
AMTB
$880M
| $221K | ﹤0.01% |
7,846
+936
| +14% | +$26.3K |
|
|
GOL
2246
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $220K | ﹤0.01% |
64,496
+38,572
| +149% | +$132K |
|
2247
Shoe Carnival
SCVL
$636M
| $220K | ﹤0.01% |
10,174
-7,943
| -44% | -$172K |
|
2248
Cardlytics
CDLX
$59.6M
| $219K | ﹤0.01% |
9,838
+7,026
| +250% | +$157K |
|
2249
DHT Holdings
DHT
$1.98B
| $219K | ﹤0.01% |
35,731
+12,234
| +52% | +$75K |
|
2250
AngioDynamics
ANGO
$433M
| $218K | ﹤0.01% |
11,274
-826
| -7% | -$16K |
|